The Role of DPP-4 Inhibitors in Cardiovascular Protection among Type-2 Diabetic Patients; Literature Review

A combination of metabolic disorders manifested by increased blood glucose levels causes Diabetes mellitus. Patients with diabetes are more prone to morbidity and rate mortality compared the general population, a substantial contribution healthcare costs. One significant risk factors for cardiovascular problems is Mellitus. Hence, additional beneficial effect has been reported in various new antidiabetic agents, including DPP-4 inhibitor